Moreover,
There is a correlation supported by studies between between vertex baldness (androgenetic alopecia), IGF-1 and prostate cancer.
The association shown between testosterone, IGF-1 and Androgenetic Alopecia:
Signorello L. B., Wuu J., Hsieh C. C., Tzonou A., Trichopoulos D., Mantzor C. S. Hormones and hair patterning in men: a role for insulin-like growth factor 1?. J. Am. Acad. Dermatol., 40: 200-203, 1999.
Associations between IGF-1 and Prostate cancer:
Chan J. M., Stampfer M. J., Giovannucci E., Gann P. H., Ma J., Wilkinson P., Henneckens C. H., Pollack M. Plasma insulin-like growth factor 1 and prostate cancer risk: a prospective study. Science (Wash. DC), 279: 563-566, 1998.
Prostate Cancer associated with vertex balding:
http://cebp.aacrjournals.org/cgi/conten ... f_ipsecsha
Association between male pattern baldness and Prostate cancer (4000 + particpants)
http://cebp.aacrjournals.org/cgi/conten ... f_ipsecsha
Androgenetic alopecia and Prostate cancer link association/link:
http://cebp.aacrjournals.org/cgi/conten ... /6/549#B13
***IGF-1 can lead to aberrant activation of the Androgen Receptor***
Blok G. J., de Boer H., Gooren L. J., van der Veen E. A. Growth hormone substitution in adult growth hormone-deficient men augments androgen effects on the skin. Clin. Endocrinol., 47: 29-36, 1997
IGF-1 & Prostate Cancer risk:
http://www.sciencemag.org/cgi/content/a ... f_ipsecsha
*** 'Aberrant activation of the Androgen Receptor has been demonstrated in vitro with IGF-1, keratinocyte growth factor, and epidermal growth factor. These agents can directly activate the Androgen Receptor in the absence of androgens and may contribute to the progression of prostate cancer and Androgenetic Alopecia'***
Yeh S., Miyamoto H., Shima H., Chang C. From estrogen to androgen receptor: a new pathway for sex hormones in prostate. Proc. Natl. Acad. Sci. USA, 95: 5527-5532, 1998.
Culig Z., Hobisch A., Cronauer M. V., Radmayr C., Trapman J., Hittmair A., Bartsch G., Klocker H. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor I, keratinocyte growth factor, and epidermal growth factor. Cancer Res., 54: 5474-5478, 1994.
In Women:
CONCLUSIONS
Overdosage of IGF-I can lead to androgenization, a previously undescribed undesirable effect of IGF-I. Long-term IGF-I treatment necessitates progressive adjustment of the IGF-I dose to avoid overtreatment.
http://www.blackwell-synergy.com/links/ ... 98.00356.x
Bear in mind the Pre-War Japanese didn't eat dairy.